{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:57:54Z","timestamp":1785326274090,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s10147-024-02536-w","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T06:43:55Z","timestamp":1715237035000},"page":"889-898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8861-1778","authenticated-orcid":false,"given":"Masamitsu","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisa","family":"Iba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Akechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Iihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyo K.","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Satomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuhei","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako Eguchi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narikazu","family":"Boku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Okita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Aogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Iino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"issue":"2","key":"2536_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.12618","volume":"26","author":"D Lorusso","year":"2017","unstructured":"Lorusso D, Bria E, Costantini A et al (2017) Patients' perception of chemotherapy side effects: Expectations, doctor\u2212patient communication and impact on quality of life - An Italian survey. Eur J Cancer Care (Engl) 26(2):e12618","journal-title":"Eur J Cancer Care (Engl)"},{"key":"2536_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00520-023-07978-y","volume":"31","author":"R Chow","year":"2023","unstructured":"Chow R, Yin LB, Baqri W et al (2023) Prevalence and predictors of long-delayed (> 120 h) chemotherapy-induced nausea and vomiting (CINV)-a systematic review and individual patient data meta-analysis. Support Care Cancer 31:505","journal-title":"Support Care Cancer"},{"key":"2536_CR3","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1056\/NEJMra0706547","volume":"358","author":"PJ Hesketh","year":"2008","unstructured":"Hesketh PJ (2008) Chemotherapy-induced nausea and vomiting. N Engl J Med 358:2482\u20132494","journal-title":"N Engl J Med"},{"key":"2536_CR4","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1002\/1097-0142(19881215)62:12<2607::AID-CNCR2820621226>3.0.CO;2-S","volume":"62","author":"MA Andrykowski","year":"1988","unstructured":"Andrykowski MA, Jacobsen PB, Marks E et al (1988) Prevalence, predictors, and course of anticipatory nausea in women receiving adjuvant chemotherapy for breast cancer. Cancer 62:2607\u20132613","journal-title":"Cancer"},{"key":"2536_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000226675","volume":"46","author":"E Alba","year":"1989","unstructured":"Alba E, Bastus R, de Andres L et al (1989) Anticipatory nausea and vomiting: prevalence and predictors in chemotherapy patients. Oncology 46:26\u201330","journal-title":"Oncology"},{"issue":"Suppl 1","key":"2536_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000227633","volume":"53","author":"GR Morrow","year":"1996","unstructured":"Morrow GR, Rosenthal SN (1996) Models, mechanisms and management of anticipatory nausea and emesis. Oncology 53(Suppl 1):4\u20137","journal-title":"Oncology"},{"key":"2536_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejphar.2013.09.071","volume":"722","author":"C Kamen","year":"2014","unstructured":"Kamen C, Tejani MA, Chandwani K et al (2014) Anticipatory nausea and vomiting due to chemotherapy. Eur J Pharmacol 722:172\u2013179","journal-title":"Eur J Pharmacol"},{"key":"2536_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1300\/J077v10n02_04","volume":"10","author":"T Hursti","year":"1992","unstructured":"Hursti T, Fredikson M, B\u00f6rjeson S et al (1992) Association between personality characteristics and the prevalence and extinction of conditioned nausea after chemotherapy. J Psychosoc Oncol 10:59\u201377","journal-title":"J Psychosoc Oncol"},{"key":"2536_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/bs.irn.2015.09.001","volume":"125","author":"MA Sticht","year":"2015","unstructured":"Sticht MA, Rock EM, Limebeer CL et al (2015) Endocannabinoid mechanisms influencing nausea. Int Rev Neurobiol 125:127\u2013162","journal-title":"Int Rev Neurobiol"},{"key":"2536_CR10","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJMra1515442","volume":"374","author":"RM Navari","year":"2016","unstructured":"Navari RM, Aapro M (2016) Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med 374:1356\u20131367","journal-title":"N Engl J Med"},{"key":"2536_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1200\/JCO.2015.64.3635","volume":"34","author":"PJ Hesketh","year":"2016","unstructured":"Hesketh PJ, Bohlke K, Lyman GH et al (2016) Antiemetics: American Society of Clinical Oncology Focused Guideline Update. J Clin Oncol 34:381\u2013386","journal-title":"J Clin Oncol"},{"key":"2536_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00000421-199504000-00017","volume":"18","author":"IA Malik","year":"1995","unstructured":"Malik IA, Khan WA, Qazilbash M et al (1995) Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. Am J Clin Oncol 18:170\u2013175","journal-title":"Am J Clin Oncol"},{"key":"2536_CR13","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1200\/JCO.1993.11.7.1384","volume":"11","author":"D Razavi","year":"1993","unstructured":"Razavi D, Delvaux N, Farvacques C et al (1993) Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. J Clin Oncol 11:1384\u20131390","journal-title":"J Clin Oncol"},{"key":"2536_CR14","unstructured":"National Comprehensive Cancer Network (2024) NCCN Guidelines Version 1: Antiemesis, https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/antiemesis.pdf. Accessed 7 Mar 2024"},{"key":"2536_CR15","doi-asserted-by":"publisher","first-page":"e1073","DOI":"10.1002\/onco.13716","volume":"26","author":"M Aapro","year":"2021","unstructured":"Aapro M, Scott\u00e9 F, Escobar Y et al (2021) Practice Patterns for Prevention of Chemotherapy-Induced Nausea and Vomiting and Antiemetic Guideline Adherence Based on Real-World Prescribing Data. Oncologist 26:e1073\u2013e1082","journal-title":"Oncologist"},{"key":"2536_CR16","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1200\/JCO.20.01296","volume":"38","author":"PJ Hesketh","year":"2020","unstructured":"Hesketh PJ, Kris MG, Basch E et al (2020) Antiemetics: ASCO Guideline Update. J Clin Oncol 38:2782\u20132797","journal-title":"J Clin Oncol"},{"key":"2536_CR17","unstructured":"National Comprehensive Cancer Network (2022) NCCN Clinical Practice Guidelines in Oncology: Antiemesis. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=3&id=1415. Accessed 7 Mar 2024"},{"key":"2536_CR18","unstructured":"Multinational association of supportive care in cancer, European society for medical oncology (2016) MASCC\/ESMO antiemetic guideline. https:\/\/mascc.memberclicks.net\/assets\/Guidelines-Tools\/Antiemetics\/mascc_antiemetic_guidelines_english_v.1.5SEPT29.2019.pdf. Accessed 7  Mar 2024"},{"key":"2536_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int J Surg 88:105906","journal-title":"Int J Surg"},{"key":"2536_CR20","unstructured":"Minds Manual Developing Committee ed. (2016) Minds Manual for Guideline Development 2017. Tokyo: Japan Council for Quality Health Care."},{"key":"2536_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.14710\/nmjn.v10i3.26027","volume":"10","author":"D Hamdani","year":"2020","unstructured":"Hamdani D, Prasetyo A, Anggorowati A (2020) The effect of hypnotherapy on anticipatory nausea in head and neck cancer patients undergoing chemotherapy. Nurse Media J Nurs 10:317\u2013328","journal-title":"Nurse Media J Nurs"},{"key":"2536_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/2156587217706617","volume":"22","author":"AS Anestin","year":"2017","unstructured":"Anestin AS, Dupuis G, Lanct\u00f4t D et al (2017) The effects of the Bali Yoga Program for breast cancer patients on chemotherapy-induced nausea and vomiting: Results of a partially randomized and blinded controlled trial. J Evid Based Complementary Altern Med 22:721\u2013730","journal-title":"J Evid Based Complementary Altern Med"},{"key":"2536_CR23","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1365-2354.2006.00739.x","volume":"16","author":"RM Raghavendra","year":"2007","unstructured":"Raghavendra RM, Nagarathna R, Nagendra HR et al (2007) Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients. Eur J Cancer Care (Engl) 16:462\u2013474","journal-title":"Eur J Cancer Care (Engl)"},{"key":"2536_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000012144","volume":"59","author":"G Marchioro","year":"2000","unstructured":"Marchioro G, Azzarello G, Viviani F et al (2000) Hypnosis in the treatment of anticipatory nausea and vomiting in patients receiving cancer chemotherapy. Oncology 59:100\u2013104","journal-title":"Oncology"},{"key":"2536_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1037\/0278-6133.11.4.250","volume":"11","author":"GR Morrow","year":"1992","unstructured":"Morrow GR, Asbury R, Hammon S et al (1992) Comparing the effectiveness of behavioral treatment for chemotherapy-induced nausea and vomiting when administered by oncologists, oncology nurses, and clinical psychologists. Health Psychol 11:250\u2013256","journal-title":"Health Psychol"},{"key":"2536_CR26","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1056\/NEJM198212093072402","volume":"307","author":"GR Morrow","year":"1982","unstructured":"Morrow GR, Morrell C (1982) Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy. N Engl J Med 307:1476\u20131480","journal-title":"N Engl J Med"},{"key":"2536_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0277-5379(83)90418-2","volume":"19","author":"A Coates","year":"1983","unstructured":"Coates A, Abraham S, Kaye SB et al (1983) On the receiving end\u2013patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19:203\u2013208","journal-title":"Eur J Cancer Clin Oncol"},{"key":"2536_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s005200100273","volume":"9","author":"G Dranitsaris","year":"2001","unstructured":"Dranitsaris G, Leung P, Warr D (2001) Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study. Support Care Cancer 9:611\u2013618","journal-title":"Support Care Cancer"},{"key":"2536_CR29","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00520-014-2146-y","volume":"22","author":"A Okuyama","year":"2014","unstructured":"Okuyama A, Nakamura F, Higashi T (2014) Prescription trends of prophylactic antiemetics for chemotherapy-induced nausea and vomiting in Japan. Support Care Cancer 22:1789\u20131795","journal-title":"Support Care Cancer"},{"key":"2536_CR30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10147-015-0786-7","volume":"20","author":"K Tamura","year":"2015","unstructured":"Tamura K, Aiba K, Saeki T et al (2015) Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. Int J Clin Oncol 20:855\u2013865","journal-title":"Int J Clin Oncol"},{"key":"2536_CR31","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1007\/s00520-013-1801-z","volume":"21","author":"S Koch","year":"2013","unstructured":"Koch S, Wein A, Siebler J et al (2013) Antiemetic prophylaxis and frequency of chemotherapy-induced nausea and vomiting in palliative first-line treatment of colorectal cancer patients: the Northern Bavarian IVOPAK I Project. Support Care Cancer 21:2395\u20132402","journal-title":"Support Care Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-024-02536-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-024-02536-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-024-02536-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T10:07:12Z","timestamp":1719223632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-024-02536-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["2536"],"URL":"https:\/\/doi.org\/10.1007\/s10147-024-02536-w","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Eriko Satomi received honoraria from Shionogi & Co., Ltd. Masayuki Takeda received honoraria from Chugai Pharmaceutical Co., Ltd., AstraZeneca K.K., Novartis Pharma K.K., Ono Pharmaceutical Co., Ltd., and Bayer. Takako Eguchi Nakajima received research funding from KBBM, Inc. and Takeda Pharmaceutical Co., Ltd. Junichi Nishimura received honoraria from Taiho Pharmaceutical Co., Ltd. Narikazu Boku received honoraria from Ono Pharmaceutical Co., Ltd., Bristol Myers Squibb, Daiichi Sankyo Co., Ltd., Taiho Pharmaceutical Co., Ltd., and Eli Lilly Japan K.K. Koji Matsumoto received honoraria from MSD K.K., Kyowa Kirin Co., Ltd., and Chugai Pharmaceutical Co., Ltd. as well as research funding from Daiichi Sankyo Co., Ltd., MSD K.K., Gilead Sciences, Inc., and Eli Lilly Japan K.K. Nobuyuki Yamamoto received honoraria from MSD K.K., Accuray Japan K.K., AstraZeneca K.K., Abbvie Inc., Amgen Inc., Ono Pharmaceutical Co., Ltd., Guardant Health Japan Corp., Daiichi Sankyo Co., Ltd., Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Chugai Foundation for Innovative Drug Discovery Science, Lao Tsumura Co., Ltd., Terumo Corporation, Eli Lilly Japan K.K., Nippon Kayaku Co., Ltd., Novartis AG, Pfizer Global Supply Japan Inc., Merck Biopharma Co., Ltd, Pfizer Global Supply Japan Inc., Merck Biopharma Co., Ltd., Janssen Pharmaceutical K.K., and USACO Corporation, as well as legal fees in case of iawsuit from Taiho Pharmaceutical Co., Ltd., Boehringer Ingelheim Japan, Chugai Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Nippon Kayaku Co., Ltd., Prime Research Institute for Medical RWD, Inc., AstraZeneca K.K., and A2 Healthcare Corporation. Other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}